| Product Code: ETC7628577 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The drug and gene delivery systems import shipments to Ireland have shown significant growth in 2024, with key exporting countries being Germany, UK, USA, Canada, and other miscellaneous areas. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), has increased from moderate to high in 2024, indicating a more competitive landscape. The impressive compound annual growth rate (CAGR) of 23.25% from 2020 to 2024 and a remarkable growth rate of 68.68% from 2023 to 2024 highlight the strong demand and flourishing market for drug and gene delivery systems in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Drug and Gene Delivery Systems Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Drug and Gene Delivery Systems Market - Industry Life Cycle |
3.4 Ireland Drug and Gene Delivery Systems Market - Porter's Five Forces |
3.5 Ireland Drug and Gene Delivery Systems Market Revenues & Volume Share, By Delivery System, 2022 & 2032F |
3.6 Ireland Drug and Gene Delivery Systems Market Revenues & Volume Share, By Gene Delivery Systems, 2022 & 2032F |
3.7 Ireland Drug and Gene Delivery Systems Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Ireland Drug and Gene Delivery Systems Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Ireland Drug and Gene Delivery Systems Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development for drug and gene delivery systems in Ireland |
4.2.2 Growing prevalence of chronic diseases requiring advanced drug delivery solutions |
4.2.3 Technological advancements leading to the development of more efficient and targeted delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug and gene delivery systems in Ireland |
4.3.2 High costs associated with the development and commercialization of innovative delivery technologies |
5 Ireland Drug and Gene Delivery Systems Market Trends |
6 Ireland Drug and Gene Delivery Systems Market, By Types |
6.1 Ireland Drug and Gene Delivery Systems Market, By Delivery System |
6.1.1 Overview and Analysis |
6.1.2 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Delivery System, 2022 - 2032F |
6.1.3 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Drug Delivery Systems, 2022 - 2032F |
6.2 Ireland Drug and Gene Delivery Systems Market, By Gene Delivery Systems |
6.2.1 Overview and Analysis |
6.2.2 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Viral Gene Delivery, 2022 - 2032F |
6.2.3 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Non-viral Gene Delivery, 2022 - 2032F |
6.2.4 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Combined Hybrid System, 2022 - 2032F |
6.3 Ireland Drug and Gene Delivery Systems Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.3 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.3.4 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3.5 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Transdermal, 2022 - 2032F |
6.3.6 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Ocular, 2022 - 2032F |
6.3.7 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Nasal, 2022 - 2032F |
6.4 Ireland Drug and Gene Delivery Systems Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.4.3 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.4.4 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Ophthalmology, 2022 - 2032F |
6.4.5 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Urology, 2022 - 2032F |
6.4.6 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.4.7 Ireland Drug and Gene Delivery Systems Market Revenues & Volume, By CNS, 2022 - 2032F |
7 Ireland Drug and Gene Delivery Systems Market Import-Export Trade Statistics |
7.1 Ireland Drug and Gene Delivery Systems Market Export to Major Countries |
7.2 Ireland Drug and Gene Delivery Systems Market Imports from Major Countries |
8 Ireland Drug and Gene Delivery Systems Market Key Performance Indicators |
8.1 Number of patents filed for drug and gene delivery systems in Ireland |
8.2 Percentage of healthcare professionals adopting advanced delivery systems |
8.3 Rate of adoption of personalized medicine using gene delivery systems in Ireland |
9 Ireland Drug and Gene Delivery Systems Market - Opportunity Assessment |
9.1 Ireland Drug and Gene Delivery Systems Market Opportunity Assessment, By Delivery System, 2022 & 2032F |
9.2 Ireland Drug and Gene Delivery Systems Market Opportunity Assessment, By Gene Delivery Systems, 2022 & 2032F |
9.3 Ireland Drug and Gene Delivery Systems Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Ireland Drug and Gene Delivery Systems Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Ireland Drug and Gene Delivery Systems Market - Competitive Landscape |
10.1 Ireland Drug and Gene Delivery Systems Market Revenue Share, By Companies, 2025 |
10.2 Ireland Drug and Gene Delivery Systems Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here